Both omega 3 fatty acids and omega 6 fatty acids seem to contribute to reductions in coronary risk. 4 According to statistics from the United Nations Food and Agricultural Organisation, w1 w2 the increase in polyunsaturated fat in Poland during the 1990s was primarily from rapeseed and to a lesser degree from soya bean oil; intake of omega 3 and omega 6 fatty acid would therefore have increased, making it difficult to distinguish their relative contributions to the drop in mortality. Statistics from the Food and Agricultural Organisation do not consider changes during processing; but a conscious effort was made in Poland to minimise the trans fat content of margarines made from these oils. In Poland many food subsidies, in particular for animal fats, were abolished. Wider availability and lower prices for unsaturated fats and fruits caused rapid dietary changes. Zatonski and Willett explore the impact of these changes, suggesting that the reduction of over a third of coronary heart disease in Poland between 1990 and 2002 can be attributed mainly to increased consumption of polyunsaturated fats, with sustained reduction in saturated fats.
1 They estimate that the small reduction in smoking and the increase in the intake of imported fruit have made little impact on cardiovascular disease.
The paper clearly shows that dietary change had a major impact on cardiovascular mortality, but the Ratio of dietary polyunsaturated to saturated fat and mortality due to coronary heart disease in Poland (relative to rates in 1990), superimposed on the relation between the fat ratio and coronary risk observed in the nurses' health study. Changes in dietary polyunsaturated to saturated fat in Poland between 1990 and 1999 are predicted to result in a 24% drop in coronary mortality, which is similar to the observed decline
What is already known on this topic
Mortality due to coronary heart disease fell drastically in Poland between 1990 and 1994 What this study adds The introduction of a market economy had major consequences for domestic production and the retail sector. There has been large investment in agriculture, with central European producers now integrated with wider European agricultural production. Much nontraditional produce is now grown locally, and fruits and vegetables are available to consumers throughout the year. Consequently, to capture the full impact of changing availability of food since the 1990s, the changes in both the total and the seasonal consumption of all fruits and vegetables need to be taken into account.
Zatonski and Willett also show that it is possible to achieve quite remarkable reductions in deaths from cardiovascular disease over a short period. Yet, in Poland, this has been achieved mainly by economic and agricultural policies, and not health policies. In contrast, policies advocated by health ministries, exemplified by the English white paper Choosing Health (www.dh.gov.uk), remain focused on medical models of education and behaviour change, even though these have had little impact on rising rates of unhealthy diets and obesity.
The health gains achieved in Poland, however, may be threatened. The European Union's Common Agricultural Policy, introduced in the 1950s, is a major determinant of what people in Europe eat 4 but fails to produce the range of foods that would allow the EU population to meet basic healthy eating guidelines. 5 As Poland and others implement the Common Agricultural Policy-following accession to the EU in 2004-they risk suffering the consequences of policy that places large scale agricultural production and economics above health. Studies in some countries, such as Slovenia and Sweden, have shown numerous adverse health effects of the Common Agricultural Policy, including the externalised costs on non-communicable diseases and obesity through subsidies for production and consumption of animal fats, tobacco and alcohol, and insufficient supply of fruits and vegetables.
5 Reform of the policy is again high on the political agenda. However, current debates about the EU budget between the UK prime minister, Tony Blair, and the French president, Jacques Chirac, are characterised more by political horse trading than the possibility of supporting poor and rural populations while also improving the diet and health of all Europeans.
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Participants, methods, and results
Lung cancer mortality can provide a useful measure of a population's exposure to smoking, 2 3 especially the population segment aged 35-54, when around 80-90% of cases are caused by smoking. We used trends, for each sex, in age standardised mortality due to lung cancer for ages 35-54 to map the lagged effects of the smoking epidemic in the 15 original EU member states and new members from central and eastern Europe, and to infer the earlier trends in tobacco exposure. We calculated death rates, using five year age groups, from deaths attributed to lung cancer in national data and population estimates submitted to the World Health Organization (http://www3.who.int/whosis/mort/text/ download.cfm?path = whosis,mort,mort_download& language = English).
Most EU countries, including all new member states from central and eastern Europe, are now experiencing falling death rates from lung cancer in men. Four countries are, however, exempt from this favourable trend: Portugal, Greece, Spain, and France show no evidence of a decline across the 35-54 age range (figure).
Mortality from lung cancer in women is still rising in most EU countries, except for the United Kingdom and, to some extent, Ireland and Denmark. The greatest increases in the past decade were observed in France, Spain, and Hungary; the estimated annual percentage changes are 7.2%, 6.8%, and 6%, respectively. In Latvia, Lithuania, Spain, and Portugal, death rates due to lung cancer remain very low. Rates for women in Hungary exceed those for women in all other member states (mirroring those for Hungarian men) and also exceed the rates for men in more than half the states in the EU. In three countries, lung cancer rates among women are the same as or higher than those 
